特徴

• Description：ELISA Set for Accurate Quantitation of Neomycin
• Neomycin is an aminoglycoside antibiotic that fights bacteria in the body.
• Neomycin is used to reduce the risk of
• infection during surgery of your intestines.
• Due to the causes of anaphylactic reaction and resistance, in EU, US
• and China, it is being restricted.
• The common instrumental analysis of this drug is limited because of the
• complicated operation and high expense, while this kit is a new product based on ELISA technology, which is fast,
• easy, accurate and sensitive compared with common instrumental analysis and only needs 1.5 hours in one
• detection, so it can considerably minimize operation error and work intensity.
• About the kit：
• - Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
• - Recovery rates are between 85 - 115％
• - Ready to use with a standard protocol with break-apart pre-coated wells
• - Validated as per US FDA guidelines for Bioassays
• - Optimized for matrix effects to ensure higher sensitivity.
• - Shelf life： 1 year
• KRIBIOLISA Neomycin ELISA kit is based on indirect-competitive ELISA.
• The microtiter wells are coated with
• antigen.
• Neomycin residue in the sample competes with antigen coated on the microtitre plate for the antibody.
• After the addition of enzyme conjugate immune complex will form.
• After washing, addition of Substrate A and
• Substrate B is used to show the color.
• Absorbance of the sample is negatively related to the Neomycin residue in
• it, after comparing with the Standard Curve, multiplied by the dilution factor, Neomycin residue in the sample can
• be calculated.